Eve Barys/LinkedIn
May 7, 2026, 15:34
Eve Barys: What’s New – Thrombosis in Immune Thrombocytopenia
Eve Barys, Sr. Strategic Account Executive at Wolters Kluwer Health, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP) is generally associated with bleeding, but individuals with ITP can also develop thrombosis.
A study of ITP documented venous thrombosis in about 4 percent of patients.
Features associated with thrombosis included older age, prior thrombosis, secondary ITP, and use of a thrombopoietin receptor agonist.
Management with anticoagulation is appropriate, and some individuals may require more intensive ITP therapies to raise the platelet count and allow for full anticoagulation.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers